Endocrinology, Vol 125, 334-341, Copyright © 1989 by Endocrine Society

ARTICLES

Evidence for neuropeptide Y synthesis in the rat anterior pituitary and the influence of thyroid hormone status: comparison with vasoactive intestinal peptide, substance P, and neurotensin

PM Jones, MA Ghatei, J Steel, D O'Halloran, G Gon, S Legon, JM Burrin, U Leonhardt, JM Polak and SR Bloom
Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

Neuropeptide Y (NPY), a 36-amino acid member of the pancreatic polypeptide family, was found to be present by RIA and immunocytochemistry in the rat anterior pituitary gland. NPY prohormone messenger RNA (mRNA) was identified in the pituitary by Northern blot analysis. The possible regulation of NPY was examined by determining the effects of thyroid hormone manipulation on peptide synthesis. Three other anterior pituitary neuropeptides, neurotensin (NT), substance P (SP), and vasoactive intestinal peptide (VIP), were studied for comparison. Hypothyroidism was found to significantly increase the pituitary content of NPY, SP, and VIP and their respective mRNAs but to decrease the quantity of NT. Immunocytochemistry revealed very weak NPY immunoreactivity in scattered cells in control rat anterior pituitaries, but in hypothyroid rats a greater number of positive cells were seen, and the staining was relatively intense. These positive cells were identified as a subset of thyrotropes. In T4-induced hyperthyroidism NPY, NT, and VIP levels were unaffected whereas SP concentrations fell considerably. TRH treatment produced a decrease in NT and had no effect on NPY, SP, or VIP. These changes were found only in the pituitary; no net change occurred in hypothalamic peptide and mRNA levels. Since the changes in pituitary peptide and mRNA levels occurred coordinately it appears that regulation by thyroid hormone status occurs, at least in part, directly at the level of gene transcription. The changes in these 4 regulatory peptides in hypothyroidism and their known powerful effects on pituitary function suggest that they may have a significant paracrine or autocrine influence in controlling the alterations in pituitary secretion.

This article has been cited by other articles:

				K. L. Smith, M. Patterson, W. S. Dhillo, S. R. Patel, N. M. Semjonous, J. V. Gardiner, M. A. Ghatei, and S. R. Bloom Neuropeptide S Stimulates the Hypothalamo-Pituitary-Adrenal Axis and Inhibits Food Intake Endocrinology, July 1, 2006; 147(7): 3510 - 3518. [Abstract] [Full Text] [PDF]

				O. Gomez and J. A. Balsa Autocrine/Paracrine Action of Pituitary Vasoactive Intestinal Peptide on Lactotroph Hyperplasia Induced by Estrogen Endocrinology, October 1, 2003; 144(10): 4403 - 4409. [Abstract] [Full Text] [PDF]

				H. L. Ward, C. J. Small, K. G. Murphy, A. R. Kennedy, M. A. Ghatei, and S. R. Bloom The Actions of Tuberoinfundibular Peptide on the Hypothalamo-Pituitary Axes Endocrinology, August 1, 2001; 142(8): 3451 - 3456. [Abstract] [Full Text] [PDF]

				Q.-L. Li, E. Jansen, G. A. Brent, and T. C. Friedman Regulation of prohormone convertase 1 (PC1) by thyroid hormone Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E160 - E170. [Abstract] [Full Text] [PDF]

				Q.-L. Li, E. Jansen, G. A. Brent, S. Naqvi, J. F. Wilber, and T. C. Friedman Interactions between the Prohormone Convertase 2 Promoter and the Thyroid Hormone Receptor Endocrinology, September 1, 2000; 141(9): 3256 - 3266. [Abstract] [Full Text] [PDF]

				R. El Meskini, R. E. Mains, and B. A. Eipper Cell Type-Specific Metabolism of Peptidylglycine {alpha}-Amidating Monooxygenase in Anterior Pituitary Endocrinology, August 1, 2000; 141(8): 3020 - 3034. [Abstract] [Full Text] [PDF]

				A. Matsuno, H. Katakami, N. Sanno, Y. Ogino, R. Y. Osamura, S. Matsukura, N. Shimizu, and T. Nagashima Pituitary Somatotroph Adenoma Producing Growth Hormone (GH)-Releasing Hormone (GHRH) with an Elevated Plasma GHRH Concentration: A Model Case for Autocrine and Paracrine Regulation of GH Secretion by GHRH J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3241 - 3247. [Abstract] [Full Text]

				N. Sanno, L. Jin, X. Qian, R. Y. Osamura, B. W. Scheithauer, K. Kovacs, and R. V. Lloyd Gonadotropin-Releasing Hormone and Gonadotropin-Releasing Hormone Receptor Messenger Ribonucleic Acids Expression in Nontumorous and Neoplastic Pituitaries J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1974 - 1982. [Abstract] [Full Text] [PDF]

				P. Leblanc, A. L'Heritier, and C. Kordon Cryptic Gonadotropin-Releasing Hormone Receptors of Rat Pituitary Cells in Culture Are Unmasked by Epidermal Growth Factor Endocrinology, February 1, 1997; 138(2): 574 - 579. [Abstract] [Full Text] [PDF]

				R. El Meskini, C. Delfino, F. Boudouresque, M. Hery, C. Oliver, and L'H. Ouafik Estrogen Regulation of Peptidylglycine {alpha}-Amidating Monooxygenase Expression in Anterior Pituitary Gland Endocrinology, January 1, 1997; 138(1): 379 - 388. [Abstract] [Full Text] [PDF]